Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Multicenter Study
. 2024 Nov;67(11):e70000.
doi: 10.1111/myc.70000.

Multicentre Study of Candida parapsilosis Blood Isolates in Türkiye Highlights an Increasing Rate of Fluconazole Resistance and Emergence of Echinocandin and Multidrug Resistance

Nevzat Ünal  1   2 , Bram Spruijtenburg  3   4   5 , Amir Arastehfar  6   7 , Ramazan Gümral  8 , Theun de Groot  4   5 , Eelco F J Meijer  3   4   5 , Hatice Türk-Dağı  9 , Asuman Birinci  10 , Süleyha Hilmioğlu-Polat  11 , Jacques F Meis  3   4   12 , Cornelia Lass-Flörl  13 , Macit Ilkit  1
Affiliations
Multicenter Study

Multicentre Study of Candida parapsilosis Blood Isolates in Türkiye Highlights an Increasing Rate of Fluconazole Resistance and Emergence of Echinocandin and Multidrug Resistance

Nevzat Ünal et al. Mycoses. 2024 Nov.

Abstract

Objectives: Worldwide emergence of clonal outbreaks caused by fluconazole-resistant (FLCR) and the recent emergence of echinocandin- and multidrug-resistant (ECR and MDR) Candida parapsilosis isolates pose serious threats to modern clinics. Conducting large-scale epidemiological studies aimed at determining the genetic composition and antifungal resistance rates is necessary to devise antifungal stewardship and infection control strategies at international, national and local levels. Despite being severely hit by outbreaks due to FLCR C. parapsilosis isolates, such knowledge at the national level is lacking in Türkiye. Herein, we conducted a prospective multicentre study involving five major clinical centres in Türkiye to determine antifungal resistance rates, underlying mechanisms and genetic composition of all isolates.

Methods: In total, 341 isolates were collected from 265 patients including clinical information. Antifungal susceptibility testing against common antifungals was performed in addition to sequencing of ERG11 and FKS1. Last, isolates were genotyped with short tandem repeat (STR) genotyping to investigate potential nosocomial transmission.

Results: The FLCR rate was 26.7% (91/341), out of which 75.8% (69/91) harboured the ERG11Y132F mutation. Patients infected with FLCR isolates had a higher mortality rate compared to their susceptible counterparts (49% for FLCR vs. 42% for susceptible). ECR rate was 2.1% (7/341) and isolates carried FKS1F652L/R658G/W1370R mutations. Concerningly, four ECR isolates were MDR. FLCR isolates grouped in distinct clusters without evidence of inter-hospital transmission, whereas large clusters containing susceptible isolates from all centres were noted.

Conclusion: Overall, the increasing prevalence of FLCR C. parapsilosis at national level and the emergence of ECR and MDR isolates pose serious clinical challenges in Türkiye. Therefore, conducting large-scale epidemiological studies are critical to determine the trend of antifungal resistance and to tailor pertinent antifungal stewardship and infection control strategies to effectively curb the spread of drug-resistant C. parapsilosis.

Keywords: Candida parapsilosis; ERG11; antifungal resistance; candidemia; echinocandins; fluconazole; genotyping.

PubMed Disclaimer

References

    1. K. Benedict, H. K. Whitham, and B. R. Jackson, “Economic Burden of Fungal Diseases in the United States,” Open Forum Infectious Diseases 9 (2022): ofac097, https://doi.org/10.1093/ofid/ofac097.
    1. D. W. Denning, “Global Incidence and Mortality of Severe Fungal Disease,” Lancet Infectious Diseases 24 (2024): e428–e438, https://doi.org/10.1016/S1473‐3099(23)00692‐8.
    1. C. F. Neoh, E. Senol, A. Kara, E. C. Dinleyici, S. J. Turner, and D. C. M. Kong, “Economic Evaluation of Micafungin Versus Liposomal Amphotericin B (LAmB) for Treating Patients With Candidaemia and Invasive Candidiasis (IC) in Turkey,” European Journal of Clinical Microbiology and Infectious Diseases 37 (2018): 1777–1784, https://doi.org/10.1007/s10096‐018‐3312‐9.
    1. A. Arastehfar, C. Lass‐Flörl, R. Garcia‐Rubio, et al., “The Quiet and Underappreciated Rise of Drug‐Resistant Invasive Fungal Pathogens,” Journal of Fungi 6 (2020): 138, https://doi.org/10.3390/jof6030138.
    1. F. Lamoth, S. R. Lockhart, E. L. Berkow, and T. Calandra, “Changes in the Epidemiological Landscape of Invasive Candidiasis,” Journal of Antimicrobial Chemotherapy 73 (2018): i4–i13, https://doi.org/10.1093/jac/dkx444.

Publication types

MeSH terms

LinkOut - more resources